SCHEMBL845086

SCHEMBL845086

CC(=O)N1CC=C[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3C=CCN3C(=O)Cc3ccccn3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.40
ITGB1 P05556 1/20 0.40
ITGA4 P13612 1/20 0.40
CYP3A4 P08684 1/20 0.40
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
CRACR2A Q9BSW2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
ATM Q13315 1/20 0.35
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
FPR3 P25089 1/20 0.35
FPR2 P25090 1/20 0.35
RAB9A P51151 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845190 0.96 EPHX2 (0.42) EPHX2ITGB1ITGA4CYP3A4MEN1
SCHEMBL845334 0.88 ITGB1 (0.39) EPHX2ITGB1ITGA4CYP3A4MEN1
SCHEMBL10119279 0.88 EPHX2 (0.37) EPHX2ITGB1ITGA4CYP3A4MEN1
SCHEMBL845441 0.88 GAA (0.43) EPHX2ITGB1ITGA4CYP3A4KDM4E
SCHEMBL845098 0.83 ITGB1 (0.43) ITGB1ITGA4HPGDKMT2ACA1
SCHEMBL845097 0.82 NAMPT (0.39) EPHX2ITGB1ITGA4MEN1KMT2A
SCHEMBL845351 0.82 ITGB1 (0.41) ITGB1ITGA4KMT2AMAPTALDH1A1
SCHEMBL10119337 0.81 ADRB1 (0.36) EPHX2ITGB1ITGA4CYP3A4HTR1A
SCHEMBL845393 0.80 GAA (0.47) EPHX2CYP3A4MEN1KMT2ANPC1
SCHEMBL845099 0.79 ITGB1 (0.44) ITGB1ITGA4HPGDKMT2ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed